Improved health-related quality of life with SSRIs and other antidepressants.
To document the health-related quality of life (HRQOL) of depressed patients receiving antidepressant drugs. Cross-sectional study. Community pharmacy-based setting. Fifty-seven depressed patients. Independent pharmacist members of the Community Pharmacists Research Network in Georgia administered the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) to subjects. Sixty-one percent of patients were treated with a selective serotonin reuptake inhibitor (SSRI) and 38.6% were treated with a non-SSRI. Those receiving SSRIs scored higher on the mean physical (PCS) and mental (MCS) health summary scores of the SF-36 than those not receiving the drugs. No significant differences were seen in PCS or MCS scores of men and women. Community pharmacists documented better HRQOL in patients receiving SSRIs than in those given other antidepressants.